Use of COPRAS decision model for the selection of best treatment alternatives in removing micropollutants: Diclofenac example

Basit Öğe Kaydı
dc.contributor.authorSimsek Yesil, Elif
dc.contributor.authorOzturk, Pınar Hasanoglu
dc.contributor.authorOzturk, Emrah
dc.contributor.authorKitis, Mehmet
dc.date.accessioned2025-10-11T20:45:20Z
dc.date.available2025-10-11T20:45:20Z
dc.date.issued2025
dc.departmentDüzce Üniversitesien_US
dc.description.abstractDiclofenac (DCF) is one of nonsteroidal anti-inflammatory drugs that is not effectively removed in drinking water and wastewater treatment plants. In recent times, DCF has been found in many drinking water sources, highlighting the increasing need to enhance current wastewater and drinking water treatment facilities through advanced treatment technologies to efficiently eliminate DCF and other micropollutants. Nonetheless, selecting the best treatment technologies is a complex matter in this modernization process, requiring multidimensional thinking and multi-criteria decision-making. This study introduces a new approach with defined multi-dimensional evaluation criteria and a multi-criteria decision-making method for choosing the best treatment alternatives and technologies. This new approach was applied and tested to determine the best treatment alternatives for DCF, one of the emerging micropollutants in this study. In this context, a total of 18 evaluation criteria were determined and prioritized. A thorough literature review was conducted to identify and assess the performance of the treatment alternatives. In determining these alternatives, the “complex proportional assessment (COPRAS)” analytical decision-making method was used in the decision-making process and their priority rankings were determined. The final priority order was determined as membrane filtration > adsorption > hybrid processes > advanced oxidation processes > artificial wetlands > oxidation processes > conventional treatment processes > biological treatment > other treatment processes. Membrane processes were discovered to be the most effective tertiary treatment alternative for DCF removal. If membrane processes are preferred as tertiary treatment in a treatment plant, the application of concentrated management techniques such as volume reduction will further increase the environmental benefit. © 2025 Elsevier B.V., All rights reserved.en_US
dc.identifier.doi10.1016/j.chemosphere.2025.144264
dc.identifier.issn0045-6535
dc.identifier.issn1879-1298
dc.identifier.pmid40022859en_US
dc.identifier.scopus2-s2.0-85218856366en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1016/j.chemosphere.2025.144264
dc.identifier.urihttps://hdl.handle.net/20.500.12684/21289
dc.identifier.volume375en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Ltden_US
dc.relation.ispartofChemosphereen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKA_Scopus_20250911
dc.subjectComplex Proportional Assessment (copras)en_US
dc.subjectDiclofenac (dcf)en_US
dc.subjectDrinking Wateren_US
dc.subjectWastewateren_US
dc.subjectDiclofenacen_US
dc.subjectAnti-inflammatory Agents, Non-steroidalen_US
dc.subjectDiclofenacen_US
dc.subjectDrinking Wateren_US
dc.subjectWastewateren_US
dc.subjectWater Pollutants, Chemicalen_US
dc.subjectBiofiltrationen_US
dc.subjectBiological Membranesen_US
dc.subjectDecision Makingen_US
dc.subjectMembrane Technologyen_US
dc.subjectMicrofiltrationen_US
dc.subjectWastewater Treatmenten_US
dc.subjectWater Filtrationen_US
dc.subjectComplex Proportional Assessmenten_US
dc.subjectComplex Proportional Assessmentsen_US
dc.subjectDiclofenacen_US
dc.subjectEvaluation Criteriaen_US
dc.subjectMembrane Processen_US
dc.subjectMicropollutantsen_US
dc.subjectNew Approachesen_US
dc.subjectTreatment Processen_US
dc.subjectTreatment Technologiesen_US
dc.subjectBiological Water Treatmenten_US
dc.subjectDiclofenacen_US
dc.subjectDrinking Wateren_US
dc.subjectNonsteroid Antiinflammatory Agenten_US
dc.subjectAdsorptionen_US
dc.subjectChemical Pollutanten_US
dc.subjectConcentration (composition)en_US
dc.subjectDrugen_US
dc.subjectFiltrationen_US
dc.subjectOxidationen_US
dc.subjectPollutant Removalen_US
dc.subjectWastewater Treatment Planten_US
dc.subjectWetlanden_US
dc.subjectArticleen_US
dc.subjectConstructed Wetlanden_US
dc.subjectDecision Modelen_US
dc.subjectEconomic Aspecten_US
dc.subjectMulticriteria Decision Analysisen_US
dc.subjectPollutanten_US
dc.subjectReduction (chemistry)en_US
dc.subjectSafetyen_US
dc.subjectWaste Water Treatment Planten_US
dc.subjectWastewateren_US
dc.subjectWater Lossen_US
dc.subjectWater Treatmenten_US
dc.subjectChemistryen_US
dc.subjectDecision Makingen_US
dc.subjectProceduresen_US
dc.subjectSewageen_US
dc.subjectWater Managementen_US
dc.subjectWater Pollutanten_US
dc.subjectAdsorptionen_US
dc.subjectAnti-inflammatory Agents, Non-steroidalen_US
dc.subjectDecision Makingen_US
dc.subjectDrinking Wateren_US
dc.subjectFiltrationen_US
dc.subjectWaste Disposal, Fluiden_US
dc.subjectWastewateren_US
dc.subjectWater Pollutants, Chemicalen_US
dc.subjectWater Purificationen_US
dc.subjectWetlandsen_US
dc.titleUse of COPRAS decision model for the selection of best treatment alternatives in removing micropollutants: Diclofenac exampleen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu